Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Molecular Dynamics Simulation and Docking Studies of Selenocyanate Derivatives As Anti-Leishmanial Agents Publisher Pubmed



Iman M1 ; Kaboutaraki HB1, 2 ; Jafari R1 ; Hosseini SA3 ; Moghimi A3 ; Khamesipour A4 ; Harchegani AB1 ; Davood A5
Authors

Source: Combinatorial Chemistry and High Throughput Screening Published:2016


Abstract

Background: Selenocyanate derivatives have been recently presented as potent anti-leishmanial agents. Objective: In this research, thirty five selenocyanate and diselenide compounds were subjected to docking studies and compared to Edelfosine and Miltefosine as reference drugs and then molecular dynamics (MD) simulation analysis. Methods: Desired Selenocyanates were built using the HyperChem program and docking calculations were performed on the crystal structure of trypanothione reductase from Leishmania infantum. Then, MD simulation analysis was performed to explore the interaction stability of selected compound during structural motions of the interacting molecules. Results: Based on the binding energy, all of the aryl rings were more potent than Edelfosine and Miltefosine as reference drug. The best compound base on hydrogen bonding, π-π interactions and orientation within the active site with high binding energy was selected for MD simulation analysis. The selected compound is known as high-affinity selective inhibitor for trypanothione reductase. Conclusion: These results can be used for future synthesis of new antileishmanial agents with better potency. © 2016 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Computational Study of Quinolone Derivatives to Improve Their Therapeutic Index As Anti-Malaria Agents: Qsar and Qstr, Iranian Journal of Pharmaceutical Research (2015)
2. Antileishmanial Activities of (Z)-2-(Nitroimidazolylmethylene)-3 (2H)-Benzofuranones: Synthesis, in Vitro Assessment, and Bioactivation by Ntr 1 and 2, Antimicrobial Agents and Chemotherapy (2022)
3. Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-Yl)-1, 3, 4-Thiadiazole-2-Yl]-4-Benzoylepiperazines, Iranian Journal of Pharmaceutical Research (2017)
Experts (# of related papers)
View all Related Experts
Alireza Foroumadi (6)
Mohammad Mahdavi (6)
Other Related Docs
4. 2, 5-Disubstituted Phthalimides: Design, Synthesis and Anticonvulsant Activity in Scptz and Mes Models, Current Computer-Aided Drug Design (2018)
5. Novel 5-(Nitrothiophene-2-Yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity Against Promastigote Stage of Leishmania Major, Iranian Journal of Pharmaceutical Research (2019)
6. Synthesis and Comparison of in Vitro Leishmanicidal Activity of 5- (Nitroheteroaryl)-1, 3, 4-Thiadiazols Containing Cyclic Amine of Piperidin-4-Ol at C- 2 With Acyclic Amine Analogues Against Iranian Strain of Leishmania Major (Mrho/Ir/75/Er), Journal of Arthropod-Borne Diseases (2017)
7. Design of Antimalarial Agents Based on Pyrimidine Derivatives As Methionine Aminopeptidase 1B Inhibitor: Molecular Docking, Quantitative Structure Activity Relationships, and Molecular Dynamics Simulation Studies, Journal of the Chinese Chemical Society (2020)
8. Structure-Based Development of 3,5-Dihydroxybenzoyl-Hydrazineylidene As Tyrosinase Inhibitor; in Vitro And in Silico Study, Scientific Reports (2024)
9. Synthesis and Evaluation of Nitrochromene Derivatives As Potential Antileishmanial Therapeutics Through Biological and Computational Studies, Scientific Reports (2025)
10. 2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives With Antiprotozoal Activities: In Vitro and in Vivo Study, Molecules (2022)
11. New Imidazo[1,2-A]Pyridin-2-Yl Derivatives As Ache, Bche, and Lox Inhibitors; Design, Synthesis, and Biological Evaluation, Letters in Drug Design and Discovery (2023)
12. Identification of Natural Inhibitors Against Cdk6 Target Using Pharmacophore-Based Screening, Molecular Docking, Molecular Dynamic Simulations, and Quantitative Electrostatic Potential Analysis Maps: A Comprehensive Study, Computational Biology and Chemistry (2025)
13. New Antimicrobial Nitro Heteroaryl-1,3,4-Thiadiazole Derivatives Containing Piperazinyl Benzonitrile Moiety: Synthesis and in Silico Study, Journal of Computational Biophysics and Chemistry (2022)
14. Design, Synthesis, in Vitro, and in Silico Studies of Novel Diarylimidazole-1,2,3-Triazole Hybrids As Potent Α-Glucosidase Inhibitors, Bioorganic and Medicinal Chemistry (2019)
15. New 4-Phenylpiperazine-Carbodithioate-N-Phenylacetamide Hybrids: Synthesis, in Vitro and in Silico Evaluations Against Cholinesterase and Α-Glucosidase Enzymes, Archiv der Pharmazie (2022)
16. Analysis of B-Rafv600einhibitors Using 2D and 3D-Qsar, Molecular Docking and Pharmacophore Studies, Molecular Diversity (2015)
17. Drug Repurposing for Targeting Fibronectin in Treatment of Endometriosis and Cancers, Journal of Biomolecular Structure and Dynamics (2023)
18. Substituted Piperazine Conjugated to Quinoline-Thiosemicarbazide As Potent Α-Glucosidase Inhibitors to Target Hyperglycemia, Scientific Reports (2025)
19. Synthesis and Biological Evaluation of 12-Aryl-11-Hydroxy-5,6-Dihydropyrrolo[2″,1″:3′,4′]Pyrazino[1′,2′:1,5]Pyrrolo[2,3-D]Pyridazine-8(9H)-One Derivatives As Potential Cytotoxic Agents, ACS Omega (2023)
20. In Vitro and in Vivo Therapeutic Potentials of 6-Gingerol in Combination With Amphotericin B for Treatment of Leishmania Major Infection: Powerful Synergistic and Multifunctional Effects, International Immunopharmacology (2021)